Medetomidine hydrochloride is a potent, highly selective α2-adrenoceptor agonist (Ki values are 1.08 and 1750 nM for α2- and α1-adrenoceptors respectively). Medetomidine hydrochloride shows greater selectivity over α1-adrenoceptors than clonidine and UK 14,304 (1620-, 220- and 300-fold respectively). Medetomidine hydrochloride is used in clinical and surgical procedures as an anesthetic and analgesic. Medetomidine hydrochloride is an imidazole derivative.
1. Savola et al (1986) Evidence for medetomidine as a selective and potent agonist at alpha 2-adrenoceptors. J.Aut.Pharmacol. 6 275.
2. Virtanen et al (1988) Characterization of the selectivity, specificity and potency of medetomidine as an a2-adrenoceptor agonist. Eur.J.Pharmacol. 150 9.
3. Scheinin et al (1989) Medetomidine - a novel a2-adrenoceptor agonist: a review of its pharmacodynamic effects. Prog.Neuro-Psychopharm.Biol.Psychiat. 13 635.
See how others have used Medetomidine hydrochloride (CAS 86347-15-1). Click on the entry to view the PubMed entry .
PMID: # 27147677 Wang, X. et al. 2016. Biomed Mater. 11: 035005.
PMID: # 26273963 You, Y. et al. 2015. J Vis Exp. e52934.